Literature DB >> 16914530

Association of leupaxin with Src in osteoclasts.

Surasri Nandan Sahu1, Mohammed Abdul Khadeer, Brian W Robertson, Stephanie M Núñez, Guang Bai, Anandarup Gupta.   

Abstract

Leupaxin (LPXN), which belongs to the paxillin extended family of adaptor proteins, was previously identified as a component of the sealing zone in osteoclasts. LPXN was found to associate with several podosomal proteins, such as the protein tyrosine kinase Pyk2, the protein-tyrosine phosphatase-PEST (PTP-PEST), actin-binding proteins, and regulators of actin cytoskeletal reorganization. It was previously demonstrated that inhibition of LPXN expression resulted in reduced osteoclast-mediated resorption. In the current study, overexpression of LPXN in murine osteoclasts resulted in both enhanced resorptive activity and cell adhesion, as assessed by in vitro resorption assays. The overexpression of LPXN resulted in an increased association of Pyk2 with LPXN. In an attempt to determine an additional biochemical basis for the observed phenomenon in increased osteoclast activity, a coimmunoprecipitation screen for additional binding partners revealed that Src, a protein tyrosine kinase that is critical to both podosome formation and osteoclast function, was also associated with LPXN. After exposure to the pro-inflammatory and osteoclastogenic cytokine TNF-alpha, there was an increase in the level of Src that coimmunoprecipitated with LPXN. Our data indicate that association of the scaffold protein LPXN with Src adds further complexity to the organization of the podosomal signaling complex in osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914530     DOI: 10.1152/ajpcell.00636.2005

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  8 in total

1.  [Small interfering RNA-mediated LPXN silencing suppresses proliferation and enhances drug sensitivity of human acute monocytic leukemia SHI-1 cells in vitro].

Authors:  Guohua Zhu; Haiping Dai; Yuanxun Duan; Zelin Yu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05

3.  The LIM protein leupaxin is enriched in smooth muscle and functions as an serum response factor cofactor to induce smooth muscle cell gene transcription.

Authors:  Liisa J Sundberg-Smith; Laura A DiMichele; Rebecca L Sayers; Christopher P Mack; Joan M Taylor
Journal:  Circ Res       Date:  2008-05-22       Impact factor: 17.367

4.  Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon.

Authors:  Sascha Dierks; Sandra von Hardenberg; Thomas Schmidt; Felix Bremmer; Peter Burfeind; Silke Kaulfuß
Journal:  Oncotarget       Date:  2015-05-30

5.  A kindlin-3-leupaxin-paxillin signaling pathway regulates podosome stability.

Authors:  Sarah Klapproth; Thomas Bromberger; Clara Türk; Marcus Krüger; Markus Moser
Journal:  J Cell Biol       Date:  2019-09-19       Impact factor: 10.539

6.  Focal adhesion kinases in adhesion structures and disease.

Authors:  Pierre P Eleniste; Angela Bruzzaniti
Journal:  J Signal Transduct       Date:  2012-07-19

7.  Role of protein-tyrosine phosphatases in regulation of osteoclastic activity.

Authors:  M H-C Sheng; K-H W Lau
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.207

8.  Leupaxin Expression Is Dispensable for B Cell Immune Responses.

Authors:  Amélie Bonaud; Simon Clare; Valeria Bisio; John M Sowerby; Shugang Yao; Hanne Ostergaard; Karl Balabanian; Kenneth G C Smith; Marion Espéli
Journal:  Front Immunol       Date:  2020-03-25       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.